Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer.
Ikesue H, Tsuji T, Hata K, Watanabe H, Mishima K, Uchida M, Egashira N, Miyamoto T, Baba E, Akashi K, Takayama K, Nakanishi Y, Tokunaga E, Okamoto T, Maehara Y, Yokomizo A, Naito S, Kubo M, Tanaka M, Masuda S.
Ikesue H, et al. Among authors: masuda s.
Ann Pharmacother. 2014 Sep;48(9):1159-1165. doi: 10.1177/1060028014539919. Epub 2014 Jun 13.
Ann Pharmacother. 2014.
PMID: 24928100